Delivery of RNAi reagents in murine models of obesity and diabetes.
Denise M. Wilcox(AbbVie (United States)), Katherine T. Landschulz(Abbott Fund), Cristina M. Rondinone(Abbott Fund), Deanna L. Haasch(Abbott Fund), Paul Jung(Abbott (United States)), Peer B. Jacobson(AbbVie (United States)), Terry J. Opgenorth(Abbott (United States)), Emily Lin(Abbott Fund), Terry Surowy(Abbott Fund), Christine A. Collins(AbbVie (United States)), Eugene N. Bush(Abbott Fund), Sherry J. Morgan(Abbott Fund), Martin J. Voorbach(AbbVie (United States)), Ruojing Yang(Quantitative BioSciences), Phong Nguyen(Children's Medical Center)
PubMed
November 29, 2006
Cited by 9
Related Papers
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice
|Proceedings of the National Academy of Sciences|2002|415
Potent and selective inhibitors of Akt kinases slow the progress of tumors <i>in vivo</i>
|Molecular Cancer Therapeutics|2005|244